Changeflow GovPing Pharma & Drug Safety EPO Patent Publication: Bioengineered Bacteria ...
Routine Notice Added Final

EPO Patent Publication: Bioengineered Bacteria for Biofilm Curation

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has published a new patent application, EP2026030202A1, concerning the use of bioengineered bacteria for curating biofilms. The publication date is March 18, 2026, and it covers various International Patent Classifications related to medical treatments and biotechnology.

What changed

This document is a patent publication from the European Patent Office (EPO) detailing a method for curating biofilms using bioengineered bacteria. The publication number is EP2026030202A1, with a publication date of March 18, 2026. It includes International Patent Classifications such as A61K 35/741, A61K 35/747, and C12N 15/74, indicating its relevance to medical applications, pharmaceuticals, and genetic engineering.

As this is a patent publication, it does not impose direct compliance obligations on regulated entities. However, companies operating in the biotechnology and pharmaceutical sectors, particularly those involved in developing treatments for conditions related to biofilms or microbial engineering, should be aware of this new intellectual property. The designation of inventors has not yet been filed, and the patent is designated for several European countries.

Source document (simplified)

← EPO Patent Bulletin

CURATING A BIOFILM USING BIOENGINEERED BACTERIA

Publication EP2026030202A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

A61K 35/741 20150101AFI20260207BHEP A61K 35/747 20150101ALI20260207BHEP A61K 6/60 20200101ALI20260207BHEP A61P 1/02 20060101ALI20260207BHEP C07K 14/315 20060101ALI20260207BHEP C12N 15/74 20060101ALI20260207BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

CURATING A BIOFILM USING BIOENGINEERED BACTERIA

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2026030202A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Biotechnology Research Drug Development
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Topics
Biotechnology Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.